Skip to main content
/
Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.310
+0.050 (2.21%)
Apr 2, 2025, 4:00 PM EDT - Market closed

Grace Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
32
Market Cap
31.69M

Revenue Chart

Created with Highcharts 11.4.8Grace Therapeutics Revenue - Annual196.00K​196.00K20202021202220232024-50K100K150K200K

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024---
Mar 31, 2023---
Mar 31, 2022---
Mar 31, 2021196.00K--
Mar 31, 2020---
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Feb 29, 2016 Pro Pro Pro
Feb 28, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings

GRCE News

More News